Audina Berrocal, M.D., is a pediatric retina specialist and world-leader in the medical and surgical management of retinopathy of prematurity and pediatric vitreoretinal disorders. Berrocal has been instrumental in the description and management of pediatric retinal disorders. She has advanced the use of fluorescein angiography in pediatric vitreoretinal disorders improving outcomes. She has also taken care of an inner-city neonatal Intensive Care Unit weekly for the past 20 years preventing blindness among the premature. Furthermore, she has been the first surgeon to treat the youngest patient in the United States with the first FDA-approved gene therapy. She has continued this novel, curative surgical treatment among children with Leber's congenital amaurosis. Not only is she a unique clinician and outstanding surgeon, but she devotes time to teaching and the support of women in the field of ophthalmology and retina. Dr. Berrocal was named to the Ophthalmologist Power List 2022.
View More
Education Background
FELLOWSHIP
Bascom Palmer Eye Institute - 2002
RESIDENCY
New England Eye Center - Tufts University - 2000
St Vincent's Hospital & Medical Center - 1997
MEDICAL SCHOOL
Tufts University School of Medicine - 1996
Languages Spoken
English
Spanish
Location & Hours
Bascom Palmer Eye Institute
900 Nw 17th St, Miami, FL 33136
Mon:8:30 am - 5:00 pm Tue:8:30 am - 5:00 pm Wed:8:30 am - 5:00 pm Thu:8:30 am - 5:00 pm Fri:8:30 am - 5:00 pm Sat:Closed Sun:Closed
Specialties Treated
Ophthalmology
Insurance Accepted
* Insurance information may change frequently. Please verify directly with the provider (doctor/clinic).